Related Experiment Video
Updated: Aug 30, 2025

Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood
Published on: April 13, 2012
Functional Impairment of Endothelial Colony Forming Cells (ECFC) in Patients with Severe Atherosclerotic
Stéphanie Simoncini1, Simon Toupance2, Carlos Labat2
1Aix Marseille Univ, INSERM, INRAE, C2VN, 13005 Marseille, France.
Insights
Atherosclerotic cardiovascular disease (ASCVD) impairs the repair capacity of endothelial progenitor cells (ECFCs), especially in severe cases. This dysfunction is linked to inflammation and cellular aging.
Area of Science:
- Cardiovascular Research
- Cell Biology
- Immunology
Background:
- Endothelial dysfunction is central to atherosclerosis development.
- The relationship between endothelial repair mechanisms and atherosclerotic cardiovascular disease (ASCVD) severity remains incompletely understood.
- Circulating endothelial progenitor cells (EPCs) are crucial for vascular repair.
Purpose of the Study:
- To investigate the link between ASCVD severity, inflammation, and the function of circulating endothelial progenitor cells, specifically endothelial colony-forming cells (ECFCs).
- To assess how ASCVD impacts the reparative and angiogenic properties of ECFCs.
- To explore the association between ECFC alterations, inflammation, and cellular senescence.
Main Methods:
- Quantified circulating progenitor cells (CD34+, CD45+CD34+KDR+) using flow cytometry in 243 subjects.
- Assessed ECFC colony-forming capacity, proliferation, senescence, and vasculogenic properties via ex vivo culture.
- Measured plasma IL-6 and VEGF-A levels using Cytokine Array.
- Correlated ECFC function with ASCVD severity (number of vascular territories involved).
Main Results:
- ASCVD patients exhibited increased circulating progenitor cells but impaired ECFC colony-forming capacity and angiogenic potential.
- These functional deficits in ECFCs were dependent on ASCVD severity.
- Impaired ECFC function correlated with an increased senescent phenotype and elevated plasma IL-6 levels.
Conclusions:
- ASCVD progressively impairs the repair capacity of ECFCs in a severity-dependent manner.
- This endothelial progenitor cell dysfunction occurs within a context of increased inflammation and cellular senescence.
- Findings highlight the role of inflammation and senescence in reduced endothelial repair in ASCVD.
Abstract:
Endothelial dysfunction is a key factor in atherosclerosis. However, the link between endothelial repair and severity of atherosclerotic cardiovascular disease (ASCVD) is unclear. This study investigates the relationship between ASCVD, markers of inflammation, and circulating endothelial progenitor cells, namely hematopoietic cells with paracrine angiogenic activity and endothelial colony forming cells (ECFC). Two hundred and forty-three subjects from the TELARTA study were classified according to the presence of clinical atherosclerotic disease. ASCVD severity was assessed by the number of involved vascular territories. Flow cytometry was used to numerate circulating progenitor cells (PC) expressing CD34 and those co-expressing CD45, CD34, and KDR. Peripheral blood mononuclear cells ex vivo culture methods were used to determine ECFC and Colony Forming Unit- endothelial cells (CFU-EC). The ECFC subpopulation was analyzed for proliferation, senescence, and vasculogenic properties. Plasma levels of IL-6 and VEGF-A were measured using Cytokine Array. Despite an increased number of circulating precursors in ASCVD patients, ASCVD impaired the colony forming capacity and the angiogenic properties of ECFC in a severity-dependent manner. Alteration of ECFC was associated with increased senescent phenotype and IL-6 levels. Our study demonstrates a decrease in ECFC repair capacity according to ASCVD severity in an inflammatory and senescence-associated secretory phenotype context.
More Related Videos
12:17Isolation and Large Scale Expansion of Adult Human Endothelial Colony Forming Progenitor Cells
Published on: October 28, 2009
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Peripheral Artery Disease I: Introduction
Atherosclerosis I: Introduction
Regulation of Hematopoietic Stem Cells